| Application no. and date | 09705212.0 (espacenet) (Federated) (European Patent Register), 20090130 | | Patent/reg. no. and date | DK/EP 2238170, 20161123 | | Publication date | 20101013 | | Priority no. and date | EP 08300061, 20080131, EP 08162683, 20080820 | | EP pub. no. and date |
EP 2238170 20101013 | | Effective date | | | Applicant/owner | INSERM - Institut National de la Santé et de la
Recherche Médicale, 101, rue de Tolbiac
75654 Paris Cedex, FR | | Applicant ref. no. | 60884DK01 | | Inventor | BONNEFOY-BERARD, Nathalie, Inst. de Recherche en Cancérologie de Montpellier
Equipe Immunité et Cancer
INSERM U896-Université de Montpellier -
CRLC Val d'Aurelle
Campus Val d'Aurelle
34298 Montpellier cedex 5, FR,
LEVY, Yves, Sce Immuno Clinique/Hôpital Henri Mondor
51 avenue Maréchal de Lattre de Tassigny
F-94010 Creteil, FR,
ELIAOU, Jean-François, Département d'Immunologie
Hôpital Saint-Eloi
CHRU Montpellier
34295 Montpellier cedex 5, FR,
BENSUSSAN, Armand, Hôpital Saint-Louis
Laboratory INSERM UMR-S 976
1, avenue Claude Vellefaux
75475 Paris cedex 10, FR | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | | Title | ANTISTOFFER MOD HUMAN CD39 OG ANVENDELSE DERAF TIL INHIBERING AF AKTIVITET AF T-REGULATORISKE CELLER | | Int. application no. | EP2009051078 | | Int. publication no. | WO2009095478 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
